Ethics in Substance Use Disorder Treatment

Psychiatric Clinics of North America

Volumn 32, Issue 2, 2009, Pages 283-297

  Geppert, Cynthia M A ^a,b   Bogenschutz, Michael P ^b  

^a NEW MEXICO VA HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Confidentiality; Ethics; Informed consent; Parity; Substance use disorders

Indexed keywords

COCAINE VACCINE; DISULFIRAM; DRUGS USED IN THE TREATMENT OF ADDICTION; NALTREXONE; NARCOTIC ANALGESIC AGENT; UNCLASSIFIED DRUG; VACCINE;

ALCOHOLISM; BENEFICENCE; CHRONIC PAIN; COCAINE DEPENDENCE; COGNITIVE DEFECT; CRIMINAL JUSTICE; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; GENETIC SCREENING; HEALTH CARE ORGANIZATION; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; MEDICAL DECISION MAKING; MEDICAL ETHICS; MEDICOLEGAL ASPECT; METHADONE TREATMENT; OPIATE ADDICTION; PATIENT COUNSELING; PATIENT EDUCATION; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; PROFESSIONAL SECRECY; PSYCHOPHARMACOLOGY; REVIEW; SOCIAL JUSTICE; STIGMA;

BEHAVIOR, ADDICTIVE; CONFIDENTIALITY; DECISION MAKING; ETHICS, MEDICAL; FORECASTING; HUMANS; INFORMED CONSENT; MANDATORY PROGRAMS; PHYSICIAN-PATIENT RELATIONS; PRACTICE GUIDELINES AS TOPIC; SOCIAL JUSTICE; SUBSTANCE-RELATED DISORDERS;

EID: 66049110106     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psc.2009.03.002     Document Type: Review

References (70)

1. Substance Abuse and Mental Health Services Administration. 2006 National survey on drug use and health (2007), Office of Applied Studies, Rockville (MD)
2. Lewin Group. The economic costs of drug abuse in the United States 1992-2002 (2004), Executive Office of the President, Office of National Drug Control Policy, Washington, DC
3. Harwood H: Updating estimates of the economic costs of alcohol abuse in the United States: Estimates, update methods and data. Report prepared by the Lewin Group for the National Institute on Alcohol Abuse and Alcoholism, 2000. Based on estimates, analyses, and data reported in Harwood, H., Fountain, D., Livermore, G. (1998). The economic costs of alcohol and drug abuse in the United States, 1992., in, 2000.
4. McGinnis J.M., and Foege W.H. Mortality and morbidity attributable to use of addictive substances in the United States. Proc Assoc Am Physicians 111 (1999) 109
5. National Institute of Drug Abuse. Drug abuse and addiction: one of America's most challenging public health problems (2008), National Institute of Drug Abuse, Rockville (MD)
6. National Strategy for Suicide Prevention. Mental illness and suicide facts (2001), Rockville (MD): U.S. Department of Health and Human Services
7. Beauchamp T.L., and Childress J.F. Principles of biomedical ethics. 5th edition (2001), Oxford University Press, New York
8. Jonsen A.R., Seigler M., and Winslade W.J. Clinical ethics. 4th edition (1998), McGraw-Hill, Inc., New York
9. White W.H. Slaying the dragon: the history of addiction treatment and recovery in America (1998), Chesnut Health Systems, Chicago
10. Link B.G., Struening E.L., Rahav M., et al. On stigma and its consequences: evidence from a longitudinal study of men with dual diagnoses of mental illness and substance abuse. J Health Soc Behav 38 (1997) 177
11. Crisp A.H., Gelder M.G., Rix S., et al. Stigmatisation of people with mental illnesses. Br J Psychiatry 177 (2000) 4
12. Roberts L.W., and Dunn L.B. Ethical considerations in caring for women with substance use disorders. Obstet Gynecol Clin North Am 30 (2003) 559
13. Brooks M.K. Legal aspects of confidentiality and patient information. In: Lowinson J.H., Ruiz P., Millman R.B., et al. (Eds). Substance abuse: a comprehensive textbook. 4th edition (2005), Lippincott Williams & Wilkins, Philadelphia 1361
14. Clark W.H., and Brooks M.K. Ethical issues in addiction treatment. In: Graham A.W., Schultz T.K., May-SMith M.F., et al. (Eds). Principles of addiction medicine. 3rd edition (2003), American Society of Addiction Medicine, Chevy Chase (MD)
15. Geppert C., and Roberts L.R. Ethical foundations of substance abuse treatment. In: Geppert C., and Roberts L.R. (Eds). The book of ethics for addiction professionals (2008), Hazelden, Center City (PA) 18
16. U.S. Department of Health and Human Services. Treatment improvement protocol 8: intensive outpatient treatment for alcohol and other drug abuse in Treatment Improvement Protocol (TIP) series (1994), Substance Abuse and Mental Health Services Administration, Rockville (MD) Chapter 7
17. Dwyer J., and Shih A. The ethics of tailoring the patient's chart. [see comments]. Psychiatr Serv 49 (1998) 1309
18. Felthous A.R. Substance abuse and the duty to protect. Bull Am Acad Psychiatry Law 21 (1993) 419
19. Bogenschutz M.P. Caring for persons with addictions. In: Roberts L.W., and Dyer A.R. (Eds). Concise guide to ethics in mental health care (2004), American Psychiatric Publishing, Washington, DC
20. Roberts L.W. Psychiatry: informed consent and care. In: Smelser N.J., and Baltes P.B. (Eds). International encyclopedia of the social and behavioral sciences (2001), Elsevier, Amsterdam
21. Appelbaum P.S. Clinical practice. Assessment of patients' competence to consent to treatment. N Engl J Med 357 (2007) 1834
22. Roberts L.W. Informed consent and the capacity for voluntarism. Am J Psychiatry 159 (2002) 705
23. Kleiman M. The "brain disease" idea, drug policy and research ethics. Addiction 98 (2003) 871
24. Bates M.E., Voelbel G.T., Buckman J.F., et al. Short-term neuropsychological recovery in clients with substance use disorders. Alcohol Clin Exp Res 29 (2005) 367
25. Koob G.F. Neurobiology of addiction. Toward the development of new therapies. Ann N Y Acad Sci 909 (2000) 170
26. Lundqvist T. Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions. Pharmacol Biochem Behav 81 (2005) 319
27. Volkow N.D., Wang G.J., Telang F., et al. Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J Neurosci 26 (2006) 6583
28. Moran M. Drug addiction erodes "free-will" over time vol 42 (2007), Psychiatric News, Washington, DC
29. Miller N.S., and Goldsmith R.J. Craving for alcohol and drugs in animals and humans: biology and behavior. J Addict Dis 20 (2001) 87
30. Wild T.C., Newton-Taylor B., and Alletto R. Perceived coercion among clients entering substance abuse treatment: structural and psychological determinants. Addict Behav 23 (1998) 81
31. Marlowe D.B., Merikle E.P., Kirby K.C., et al. Multidimensional assessment of perceived treatment-entry pressures among substance abusers. Psychol Addict Behav 15 (2001) 97
32. Seraganian P., Brown T.G., and Tremblay J. Randomization in a substance abuse treatment study: participants who consent vs those who do not. Can J Psychiatry 48 (2003) 388
33. Geppert C.M. Aristotle. Augustine and Addiction vol. 25 (2008), Psychiatric Times, Darien (CT)
34. Layde J.B. Forensic issues in the treatment of addictions. In: Geppert C.M., and Roberts L.W. (Eds). The book of ethics: expert guidance for professionals who treat addiction (2008), Hazelden, Center City (PA)
35. Klag S., O'Callaghan F., and Creed P. The use of legal coercion in the treatment of substance abusers: an overview and critical analysis of thirty years of research. Subst Use Misuse 40 (2005) 1777
36. Sullivan M.A., Birkmayer F., Boyarsky B.K., et al. Uses of coercion in addiction treatment: clinical aspects. Am J Addict 17 (2008) 36
37. Cohen P.J. Addiction, molecules and morality: disease does not obviate responsibility. Am J Bioeth 7 (2007) 21
38. Morse S.J. Medicine and morals, craving and compulsion. Subst Use Misuse 39 (2004) 437
39. Caplan A.L. Ethical issues surrounding forced, mandated, or coerced treatment. J Subst Abuse Treat 31 (2006) 117
40. McCrady B.S., and Bux Jr. D.A. Ethical issues in informed consent with substance abusers. J Consult Clin Psychol 67 (1999) 186
41. Forman R.F., Bovasso G., Woody G., et al. Staff beliefs about drug abuse clinical trials. J Subst Abuse Treat 23 (2002) 55
42. Walker R., Logan T.K., Clark J.J., et al. Informed consent to undergo treatment for substance abuse: a recommended approach. J Subst Abuse Treat 29 (2005) 241
43. Timko C., and Moos R.H. Determinants of the treatment climate in psychiatric and substance abuse programs: implications for improving patient outcomes. J Nerv Ment Dis 186 (1998) 96
44. Dunn L.B., Nowrangi M.A., Palmer B.W., et al. Assessing decisional capacity for clinical research or treatment: a review of instruments. Am J Psychiatry 163 (2006) 1323
45. Moser D.J., Reese R.L., Hey C.T., et al. Using a brief intervention to improve decisional capacity in schizophrenia research. Schizophr Bull 32 (2006) 116
46. Woolfolk R.L., and Doris J.M. Rationing mental health care: parity, disparity, and justice. Bioethics 16 (2002) 469
47. Barry C.L., and Sindelar J.L. Equity in private insurance coverage for substance abuse: a perspective on parity. Health Aff (Millwood) 26 (2007) w706
48. McLellan A.T., Lewis D.C., O'Brien C.P., et al. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 284 (2000) 1689
49. Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008, in H.R. 6983, ed 2d, 2008.
50. Kaner E.F., Beyer F., Dickinson H.O., et al. Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Rev 2 (2007) CD004148
51. Lindberg M., Vergara C., Wild-Wesley R., et al. Physicians-in-training attitudes toward caring for and working with patients with alcohol and drug abuse diagnoses. South Med J 99 (2006) 28
52. Karam-Hage M., Nerenberg L., and Brower K.J. Modifying residents' professional attitudes about substance abuse treatment and training. Am J Addict 10 (2001) 40
53. Ducharme L.J., Knudsen H.K., and Roman P.M. Trends in the adoption of medications for alcohol dependence. J Clin Psychopharmacol 26 Suppl 1 (2006) S13
54. Cunningham C.O., Kunins H.V., Roose R.J., et al. Barriers to obtaining waivers to prescribe buprenorphine for opioid addiction treatment among HIV physicians. J Gen Intern Med 22 (2007) 1325
55. Taxman F.S., Perdoni M.L., and Harrison L.D. Drug treatment services for adult offenders: the state of the state. J Subst Abuse Treat 32 (2007) 239
56. McAuliffe W.E., LaBrie R., Woodworth R., et al. State substance abuse treatment gaps. Am J Addict 12 (2003) 101
57. Roberts L.W., Johnson M.E., Brems C., et al. Ethical disparities: challenges encountered by multidisciplinary providers in fulfilling ethical standards in the care of rural and minority people. J Rural Health 23 Suppl (2007) 89
58. Bhatt R.V. Domestic violence and substance abuse. Int J Gynaecol Obstet 63 Suppl 1 (1998) S25
59. Stewart D., Gossop M., and Trakada K. Drug dependent parents: childcare responsibilities, involvement with treatment services, and treatment outcomes. Addict Behav 32 (2007) 1657
60. Marcellus L. Feminist ethics must inform practice: interventions with perinatal substance users. Health Care Women Int 25 (2004) 730
61. Abel E.L., and Kruger M. Physician attitudes concerning legal coercion of pregnant alcohol and drug abusers. Am J Obstet Gynecol 186 (2002) 768
62. Plambeck C.M. Divided loyalties. Legal and bioethical considerations of physician-pregnant patient confidentiality and prenatal drug abuse. J Leg Med 23 (2002) 1
63. Chasnoff I.J., Landress H.J., and Barrett M.E. The prevalence of illicit-drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida. N Engl J Med 322 (1990) 1202
64. Svikis D.S., and Reid-Quinones K. Screening and prevention of alcohol and drug use disorders in women. Obstet Gynecol Clin North Am 30 (2003) 447
65. Gostin L.O. The rights of pregnant women: the Supreme Court and drug testing. Hastings Cent Rep 31 (2001) 8
66. ACOG Committee Opinion. Number 294, May 2004. At-risk drinking and illicit drug use: ethical issues in obstetric and gynecologic practice. Obstet Gynecol 103 (2004) 1021
67. Hall W., and Carter L. Ethical issues in using a cocaine vaccine to treat and prevent cocaine abuse and dependence. J Med Ethics 30 (2004) 337
68. Hall W., Carter L., and Morley K.I. Neuroscience research on the addictions: a prospectus for future ethical and policy analysis. Addict Behav 29 (2004) 1481
69. Christie T., Groarke L., and Sweet W. Virtue ethics as an alternative to deontological and consequential reasoning in the harm reduction debate. Int J Drug Policy 19 (2008) 52
70. Geppert C.M. To help and not to harm: ethical issues in the treatment of chronic pain in patients with substance use disorders. Adv Psychosom Med 25 (2004) 151